Hormone Therapy Market Projected Growth Rate Through 2023-2032

The Hormone Therapy Global Market Report 2023, provides comprehensive information on the hormone therapy market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Hormone Therapy Market’s Growth:

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

The global hormone therapy market size is expected to grow from $17.34 billion in 2022 to $18.48 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hormone therapy market size is expected to grow to $23.65 billion in 2027 at a CAGR of 6.4%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9246&type=smp

Product innovation is the key trend gaining popularity in the hormone therapy market. Major companies operating in the hormone therapy market are focusing on launching new innovative treatments for hormone imbalance disorders and their symptoms to decrease side effects and introduce treatment for other symptoms. Such innovations enable key players to gain a competitive edge in the market. For instance, in May 2021, Myovant Sciences, a UK-based healthcare company, and Pfizer, a US-based biotechnology company, received FDA-approval for MYFEMBREE, a new once-daily medication administered for up to 24 months to manage premenopausal women’s excessive monthly bleeding brought on by uterine fibroids. MYFEMBREE provides clinically significant symptom alleviation for heavy menstrual bleeding in women with uterine fibroids with just one pill, taken once daily. For patients with commercial insurance, the MYFEMBREE Support Program offers services such as insurance benefit checks, prior authorization support, co-pay support, and patient assistance for eligible uninsured patients.

The hormone therapy market is segmented:

1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement

2) By Route of Administration: Oral, Parenteral, Other Routes of Administration

3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

North America was the largest region in the hormone therapy market in 2022.

The table of contents in TBRC’s hormone therapy market report includes:

1. Executive Summary
2. Hormone Therapy Market Characteristics
3. Hormone Therapy Market Trends And Strategies
4. Hormone Therapy Market – Macro Economic Scenario
5. Hormone Therapy Market Size And Growth
6. Hormone Therapy Market Segmentation
7. Hormone Therapy Market Regional And Country Analysis

.

.

.

28. Key Mergers And Acquisitions In The Hormone Therapy Market
29. Hormone Therapy Market Future Outlook and Potential Analysis
30. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model